elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27851967-51BF46F2-80E9-45A5-A8F9-84E45B5E9823
Q27851967-51BF46F2-80E9-45A5-A8F9-84E45B5E9823
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851967-51BF46F2-80E9-45A5-A8F9-84E45B5E9823
Ponatinib in refractory Philadelphia chromosome-positive leukemias.
P2860
Q27851967-51BF46F2-80E9-45A5-A8F9-84E45B5E9823
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851967-51BF46F2-80E9-45A5-A8F9-84E45B5E9823
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aed1c4bfa3249e496798298e52af896d3eb8826a
P2860
Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL